Last one week high and low of the scrip stood at Rs. 280.35 and Rs. 260.35 respectively. The current market cap of the company is Rs. 3388.90 crore. The promoters holding in the company stood at 60.00% while Institutions and Non-Institutions held 8.15% and 31.85% respectively.
Suven Life Sciences has completed the purchase of the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc. This brings closure of the purchase process for the assets of Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio, customer programs and manufacturing and drug development relationships to Shore Suven Pharma Inc.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
